Private-equity-backed Swedish biopharmaceutical company Aprea Therapeutics has raised a €50m series-C funding round led by Redmile Group, a US-based VC firm focused on healthcare.
Carve-out transaction sees special situation investor Mutares buy France-based TrefilUnion
Orlando drew capital from the €320m vehicle European Special Situations Venture Partners IV
Italian GP Alto Partners buys a majority stake in dermo-cosmetic business via its fourth fund
Predecessor fund held a €255m final close in 2017 after 21 months on the road